Enteric Softgel Capsules Market Analysis 2026

Global Enteric Softgel Capsules Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Enteric Softgel Capsules Market Report Description

We have various report editions of Enteric Softgel Capsules Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Enteric Softgel Capsules Market Insights Video

Competitive Landscape of the Enteric softgel capsule market

The competitive landscape of the enteric softgel capsule market is characterized by a diverse range of players competing to gain market share through product innovation, strategic partnerships, and aggressive marketing efforts. Key players in the market include established medicine manufacturers, specialized Pharmaceutical Companies, and emerging start-ups aiming to disrupt the market with innovative solutions.

March 2024: An agreement has been inked by Lonza to purchase the Genentech manufacturing plant located in Vacaville, US, from Roche. By volume, the Vacaville (US) location is among the biggest biologics manufacturing facilities worldwide. With this acquisition, Lonza will be able to produce biologics on a big scale for use in mammalian therapeutics and greatly expand the reach of its facility network throughout the United States. (Source: https://www.lonza.com/news/2024-03-20-07-00) February 2018: To fulfill the growing demand for K-CAPS around the world, Caps Canada invested in a new 100,000-square-foot K-CAPS plant with an additional capsule production increase; this was roughly three times the amount Caps Canada invested in an HPMC capsule expansion. (Source: https://capscanada.com/news-events/capscanada-expands-k-caps-hpmc-capsules-manufacturing-capacity-for-second-time/)

Top Companies Market Share in Enteric Softgel Capsules Industry: (In no particular order of Rank)

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive)

Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Enteric softgel capsule market

Which Region Dominates the Enteric softgel capsule market in 2024?

According to cognitive market research, North America dominated the market in 2024. It accounted for around 40% of the global revenue because of the high cost of healthcare per person in this area, growing investments in R&D to create new varieties, and growing consumer knowledge of wholesome supplements are all considered contributing factors to its growth. The North American market is dominated by large companies like Colocon Inc., which will support enteric softgel capsule demand in the upcoming years.

Which Region is Expanding at the Fastest CAGR?

Asia Pacific stands out as the fastest-growing region in the enteric softgel capsule market due to several compelling reasons. The rising incidence of nutritional problems, the expanding healthcare sector, and the increase in government spending to build the infrastructure for healthcare are all factors contributing to the expansion of this region. Furthermore, it is anticipated that in the upcoming years, this region will generate a sizable amount of money due to the increased consumer knowledge of nutritional issues, prevention, and treatments.

 

The current report Scope analyzes Enteric Softgel Capsules Market on 6 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (East Africa, West Africa, North Africa, South Africa)

The above graph is for illustrative purposes only.

North America Enteric Softgel Capsules Market Analysis

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 1018.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2031.

• According to cognitive market research, the US had a major share in the enteric softgel capsule market with a market size of USD 803.27 million in 2024 and is projected to grow at a CAGR of 3.0% during the forecast period. Nutritional deficits and other conditions are becoming more prevalent. Enteric softgels provide a means of avoiding stomach acid and maximizing absorption by delivering vital nutrients straight to the colon.
• The Canada enteric softgel capsule market had a market share of USD 122.17 million in 2024 and is projected to grow at a CAGR of 3.5% during the forecast period. Aging population in Canada, there is a growing need for vitamins and prescriptions that are easy for senior citizens to chew and digest. Enteric softgels provide a way to take drugs that could cause stomach irritation.
• The Mexico enteric softgel capsule market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 92.65 million in 2024.

Europe Enteric Softgel Capsules Market Analysis

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 763.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.0% from 2024 to 2031

• The United Kingdom enteric softgel capsule market had a market share of USD 128.28 million in 2024 and is projected to grow at a CAGR of 3.8% during the forecast period. In the UK, the population is aging, and medicine needs are increasing with age. Because enteric softgel capsules are simpler to swallow than tablets and may lessen stomach discomfort, they may be an excellent choice for older persons.
• The France enteric softgel capsule market is projected to witness growth at a CAGR of 2.2% during the forecast period, with a market size of USD 70.25 million in 2024.
• According to cognitive market research, the German enteric softgel capsule market size was valued at USD 151.18 million in 2024 and is projected to grow at a CAGR of 3.2% during the forecast period. In Germany, it serves as the center for the two main end markets for enteric capsules: the pharmaceutical and nutraceutical sectors. The demand for enteric softgel capsules was directly impacted by the expansion of these industries.
• The Italy enteric softgel capsule market is projected to witness growth at a CAGR of 2.4% during the forecast period, with a market size of USD 65.67 million in 2024.
• The Russia enteric softgel capsule market is projected to witness growth at a CAGR of 2.0% during the forecast period, with a market size of USD 118.35 million in 2024.
• The Spain enteric softgel capsule market is projected to witness growth at a CAGR of 2.1% during the forecast period with a market size of USD 62.61 million in 2024
• The Luxembourg enteric softgel capsule market is projected to witness growth at a CAGR of 3.1% during the forecast period, with a market size of USD 23.67 million in 2024.
• The Portugal enteric softgel capsule market is projected to witness growth at a CAGR of 2.8% during the forecast period, with a market size of USD 16.03 million in 2024.
• The Greece enteric softgel capsule market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 9.16 million in 2024.
• Rest of Europe's enteric softgel capsule market is projected to witness growth at a CAGR of 1.7% during the forecast period, with a market size of USD 118.35 million in 2024.

Asia Pacific Enteric Softgel Capsules Market Analysis

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 585.40 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031

• According to cognitive market research, the China enteric softgel capsule market size was valued at USD 263.43 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Chinese consumers are flocking to nutraceuticals for their health benefits and are becoming more interested in preventative healthcare.
• The Japan enteric softgel capsule market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 80.78 million in 2024.
• The India enteric softgel capsule market had a market share of USD 70.25 million in 2024 and is projected to grow at a CAGR of 8.3% during the forecast period. In India, the market is being driven by a growing awareness of the advantages of enteric softgel capsules.
• The South Korean enteric softgel capsule market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 58.54 million in 2024.
• The Australia Enteric softgel capsule market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 30.44 107.06 million in 2024.
• The South East Asia Enteric softgel capsule market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 40.39 million in 2024.
• The Rest of the Asia Pacific Enteric softgel capsule market is projected to witness growth at a CAGR of 6.3% during the forecast period, with a market size of USD 41.56 million in 2024.

South America Enteric Softgel Capsules Market Analysis

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 127.26 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.9% from 2024 to 2031

• According to cognitive market research, the Brazil enteric softgel capsule market size was valued at USD 54.47 million in 2024 and is projected to grow at a CAGR of 4.5% during the forecast period. Enteric capsules are widely used by the pharmaceutical and nutraceutical sectors in Brazil, which has a thriving life sciences sector.
• Argentina's enteric softgel capsule market had a market share of USD 21.38 million in 2024 and is projected to grow at a CAGR of 4.8% during the forecast period. Enteric softgels for supplements may become popular as Argentinians place a high priority on preventative healthcare.
• Colombia's enteric softgel capsule market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 11.33 million in 2024.
• Peru Enteric softgel capsule market is projected to witness growth at a CAGR of 4.1% during the forecast period, with a market size of USD 10.44 million in 2024.
• Chile Enteric softgel capsule market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 9.16 million in 2024.
• The Rest of Latin America Enteric softgel capsule market is projected to witness growth at a CAGR of 3.0% during the forecast period, with a market size of USD 20.49 million in 2024.

Middle East Enteric Softgel Capsules Market Analysis

According to cognitive market research, the global enteric softgel capsule market size was estimated at USD 2545.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 50.90 million in 2024 and will grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2031.

• The GCC Countries' enteric softgel capsule market is projected to witness growth at a CAGR of 5.0% during the forecast period, with a market size of USD 21.79 million in 2024. In the GCC countries, there is a growing consciousness of health and wellbeing to propel the industry.
• The Egypt Enteric softgel capsule market is projected to witness growth at a CAGR of 4.5% during the forecast period, with a market size of USD 5.34 million in 2024.
• The South Africa Enteric softgel capsule market is projected to witness growth at a CAGR of 5.2% during the forecast period, with a market size of USD 8.04 million in 2024. The South African government is driving the industry by investing in healthcare programs and infrastructure.
• The Turkey Enteric softgel capsule market is projected to witness growth at a CAGR of 3.7% during the forecast period, with a market size of USD 4.38 million in 2024.
• The Nigeria Enteric softgel capsule market is projected to witness growth at a CAGR of 3.3% during the forecast period, with a market size of USD 5.34 million in 2024.
• The Rest of the MEA Enteric softgel capsule market is projected to witness growth at a CAGR of 3.2% during the forecast period, with a market size of USD 6.01 million in 2024.

Author's Conclusion

Author's Detail

Supriya Yadav

Research Analyst at Cognitive Market Research

LinkedIn | Profile | Book Appointment

Supriya Yadav is a skilled market researcher with strong expertise in the Medical Devices and Consumables industry. Known for her analytical precision and deep interest in healthcare innovation, she focuses on decoding key market trends, technological advancements, and evolving customer needs. Supriya excels at transforming complex industry data into meaningful insights that support strategic decision-making for healthcare stakeholders. Her commitment to understanding the future of medical technologies and improving patient-centric solutions makes her a valuable contributor in this rapidly advancing sector.